Latest DEF 14A proxy statements

Enanta Pharmaceuticals, Inc. will hold its 2026 Annual Meeting to elect directors, approve a 1.6 million share increase for its equity incentive plan, and ratify executive compensation and auditor appointment.

Aptevo Therapeutics Inc. calls a special meeting to approve an amendment to its Certificate of Incorporation and a potential $60 million equity issuance under a Standby Equity Purchase Agreement.

Kala Bio, Inc. filed a supplement to its 2025 Annual Meeting proxy statement, updating the biography of Class II Director Nominee David Lazar to reflect his recent and current executive and board roles across multiple public companies.

Parks! America, Inc. announced its Annual Meeting of Stockholders for March 20, 2026, to vote on director elections, auditor ratification, and executive compensation.

Arrowhead Pharmaceuticals, Inc. announced its 2026 Annual Meeting of Stockholders to be held virtually on March 19, 2026, to vote on director elections, executive compensation, an incentive plan, and auditor ratification.

Arrowhead Pharmaceuticals, Inc. announces its 2026 Annual Meeting of Stockholders, highlighting significant financial improvements, key regulatory approvals, and pipeline advancements.

Forward Industries, Inc. seeks shareholder approval for a strategic reincorporation to Texas, an expanded equity incentive plan, and director elections at its upcoming 2026 Annual Meeting.

Destiny Media Technologies Inc. filed its definitive proxy statement for the 2026 Annual General Meeting, outlining proposals for director elections and auditor ratification.

Amicus Therapeutics provides preliminary unaudited financial results for 2025, showing robust product revenue growth ahead of its acquisition by BioMarin.

Quipt Home Medical Corp. announced the expiration of the HSR waiting period for its acquisition by 1567208 B.C. Ltd. for $3.65 per share in cash, moving the transaction closer to completion.

Xilio Therapeutics, Inc. will hold a special meeting on February 23, 2026, for stockholders to vote on a reverse stock split to meet Nasdaq's minimum bid price requirement.

Orion Properties Inc. announced a strategic options review process to maximize stockholder value and a cooperation agreement with The Kawa Fund Limited.

Gold Resource Corporation announced a definitive agreement to merge with Goldgroup Mining Inc., offering GRC stockholders a 39% premium and approximately 40% ownership in the combined company.

Blue Bird Corporation has filed definitive additional proxy soliciting materials with the SEC.

Blue Bird Corporation announces its 2026 Annual Meeting of Stockholders to vote on director elections, an expanded equity incentive plan, officer liability limitation, and executive compensation.

Compass Minerals International, Inc. announced its 2026 Annual Meeting of Stockholders to be held on March 5, 2026, outlining key proposals including director elections, executive compensation, and auditor ratification.

Sanmina Corporation has filed definitive additional proxy soliciting materials with the SEC.

Eagle Point Credit Company Inc. issues a reminder to shareholders to cast their votes for the upcoming Special Meeting.

Clearwater Analytics Holdings, Inc.'s go-shop period for its proposed merger with GT Silver BidCo, Inc. expired without any alternative acquisition proposals.

Klotho Neurosciences, Inc. will hold a Special Meeting to vote on a reverse stock split to meet Nasdaq listing requirements and an increase in its equity incentive plan to attract and retain talent.

Sealed Air Corporation's Board unanimously recommends stockholders approve the $42.15 per share all-cash acquisition by Sword Purchaser, LLC, an affiliate of Clayton, Dubilier & Rice, LLC.

Compass Minerals International, Inc. announces its 2026 annual meeting of stockholders to elect directors, approve executive compensation, and ratify auditors, alongside reporting fiscal 2025 financial highlights.

Sanmina Corporation announced robust fiscal 2025 financial results, including 7.4% revenue growth and expanded operating margins, alongside the strategic acquisition of ZT Systems to bolster its Cloud and AI infrastructure offerings.

Advanced Biomed Inc. announces a planned reverse stock split, ranging from 1:2 to 1:100, to maintain its listing on The Nasdaq Capital Market.

Flanigan's Enterprises, Inc. announced its 2026 Annual Meeting of Shareholders to be held on February 27, 2026, primarily for the election of three directors and a review of fiscal year 2025 performance, which saw significant net income growth.

Amtech Systems, Inc. announces its 2026 Annual Meeting of Shareholders to elect directors, ratify auditors, and vote on executive compensation, amidst ongoing net losses and management changes.

National Fuel Gas Company announces its 2026 Annual Meeting of Stockholders to vote on director elections, executive compensation, and auditor ratification.

National Fuel Gas Company reports strong fiscal 2025 performance with record natural gas production, strategic pipeline projects, and a significant Ohio utility acquisition, alongside continued dividend growth.

T Stamp Inc. has rescheduled its 2025 Annual Meeting of Stockholders to March 11, 2026, to vote on director elections, auditor ratification, and the crucial approval of private placement warrants.

Ellington Income Opportunities Fund seeks shareholder approval for new investment advisory and sub-advisory agreements with Princeton Fund Advisors and Ellington Global Asset Management, prompted by a potential change in control at Princeton, with no proposed fee increases.